OPPapers.com

Opinions Of Pharmaceutical Direct-To Consumer Marketing On College Students

INTRODUCTION AND LITERATURE REVIEW

Today consumers who watch television programs and read popular magazines are bombarded by drug advertisements which promise to cure a plethora of illnesses, ranging from allergies to depression. Until recently, pharmaceutical companies have been prevented from advertising directly to consumers. However, in 1997, the Food and Drug Administration (FDA) began to loosen its advertising restrictions, and "direct-to-consumer" (DTC) marketing gained popularity among pharmaceutical companies (4). In 2001 alone, $2.5 billon was spent on DTC marketing (6). Considering the large amount of money spent on this form of marketing, the goal of this research project is to determine the opinions of future consumers, current college students, on DTC marketing.

While the Federal Trade Commission monitors the advertising for most consumer products, the FDA alone must ensure that the claims given by DTC advertisements are reinforced by science (1). However, given its staff of only 13 drug-marketing reviewers and overall budgeting constraints, the FDA may find that task overwhelming (1). While the FDA requires that drug advertisements be submitted to the agency before they are aired on television or printed in magazines, not all pharmaceutical companies submit their advertisements.

Opponents of DTC marketing also argue that the increase in its popularity has led to inflated drug costs. In recent years drug spending has increased by 17% a year, in part due to rising drug prices. Currently, drug spending in the United States is greater than in any other nation (2). Critics argue that drug companies promote only the newest and most expensive "blockbuster" prescriptions, when less expensive ones may be just as effective (2).

If recent sales trends are any indication, the DTC marketing boom is certain to continue. In fact, the amount of money the pharmaceutical industry spends each year on DTC marketing is expected to approach $7.5 billion by...